A STAT investigation reported details about Commure, a $7 billion Silicon Valley company automating healthcare administrative workflows using AI, including internal referral-compensation practices. The reporting describes programs that offer compensation to clinics and other parties who refer customers to Commure and says some customers reported financial losses tied to the deployment. Commure said the referral programs are industry standard and that the majority of its hundreds of customers are satisfied. The issue lands at the intersection of healthcare automation, sales incentives, and clinical operations, where administrative systems can influence cost and quality indirectly through scheduling, billing, and documentation. For biotech and healthcare stakeholders evaluating AI-enabled vendors, the story highlights due-diligence needs around vendor incentives and measured outcomes in real clinical settings.